HKG:2359 Wuxi Apptech

HKG:2359 Wuxi Apptech

HKG:2359 Wuxi Apptech operates in the field of Biotechnology – Supplies & Services. WuXi AppTec is a company that helps other companies in the healthcare industry, mainly pharmaceutical and medical device companies, bring new drugs and treatments to market faster and more cheaply.

HKG:2359 Wuxi Apptech

Last update: 10-Jan-26

Quick overview:

    • Yield: 1.43%

(See here Top 10 highest yield)

    • Lot: 100
    • Price/Earnings ratio : 17.38 (Ideal <20 )
    • Earnings per share : 6.420 (Ideal >0.001)
    • Price as per 10-Jan-26 : HK$111.60
    • Ex-Dividend Date coming up:  N/A

See here all upcoming Ex-Dividend dates

2025 Interim results: Wuxi AppTec (2359.HK) reported excellent interim results. Return on Equity remains strong and earnings momentum is clear: EPS more than doubled (+106% YoY), driven by robust profit growth. The company also announced a first interim dividend of RMB 3.50 per 10 shares and continued its buyback program. These results highlight a profitable, shareholder-friendly business that continues to grow and reward long-term investors.

You need to be logged in to view the rest of the content. Please .